North Star Asset Management’s Edwards Lifesciences EW Stock Holding History

North Star Asset Management’s Portfolio EW Stock Details EW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$5.78M	Buy	72,225 +3,504	+5%	+$289K	0.25%	95
2025 Q4	$5.86M	Buy	68,721 +8,940	+15%	+$734K	0.24%	93
2025 Q3	$4.65M	Buy	59,781 +3,844	+7%	+$300K	0.19%	100
2025 Q2	$4.37M	Buy	55,937 +8,373	+18%	+$624K	0.19%	99
2025 Q1	$3.45M	Buy	47,564 +12,293	+35%	+$880K	0.16%	105
2024 Q4	$2.61M	Buy	35,271 +17,508	+99%	+$1.23M	0.12%	118
2024 Q3	$1.17M	Buy	+17,763	New	+$1.29M	0.05%	167

Other funds holding EW

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

North Star Asset Management's EW Position: Q1 2026 in Review

North Star Asset Management increased its Edwards Lifesciences (EW) stake by 5.1% in Q1 2026, buying an estimated $289K and bringing the position to 72,225 shares worth $5.78M. The position accounts for 0.25% of the portfolio, ranked #95.

North Star Asset Management first reported a position in EW in Q3 2024 and has held it in 7 quarters since. The position peaked at $5.86M in Q4 2025. 1,283 funds tracked by Wall St. Rank hold EW as of Q1 2026.

North Star Asset Management held 72,225 shares of Edwards Lifesciences worth $5.78M as of Q1 2026.
North Star Asset Management bought 3,504 Edwards Lifesciences shares in Q1 2026, an estimated $289K.
Edwards Lifesciences made up 0.25% of North Star Asset Management's portfolio in Q1 2026, its #95 holding.
North Star Asset Management first reported a position in Edwards Lifesciences in Q3 2024 and has held it in 7 quarters since.
North Star Asset Management's Edwards Lifesciences position peaked at $5.86M in Q4 2025.
1,283 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q1 2026.

Based on North Star Asset Management's 13F filing for Q1 2026, filed 6 May 2026.